These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7491877)

  • 1. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation.
    Spring B; Wurtman J; Wurtman R; el-Khoury A; Goldberg H; McDermott J; Pingitore R
    Am J Clin Nutr; 1995 Dec; 62(6):1181-7. PubMed ID: 7491877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight suppression and weight rebound in ex-smokers treated with fluoxetine.
    Borrelli B; Spring B; Niaura R; Kristeller J; Ockene JK; Keuthen NJ
    J Consult Clin Psychol; 1999 Feb; 67(1):124-31. PubMed ID: 10028216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity.
    Davis R; Faulds D
    Drugs; 1996 Nov; 52(5):696-724. PubMed ID: 9118819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Wellman PJ; Jones SL; Miller DK
    Pharmacol Biochem Behav; 2003 Apr; 75(1):103-14. PubMed ID: 12759118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of dexfenfluramine to fluoxetine in the treatment of obesity: a randomized clinical trial.
    Pedrinola F; Sztejnsznajd C; Lima N; Halpern A; Medeiros-Neto G
    Obes Res; 1996 Nov; 4(6):549-54. PubMed ID: 8946439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexfenfluramine hydrochloride: an anorexigenic agent.
    Bever KA; Perry PJ
    Am J Health Syst Pharm; 1997 Sep; 54(18):2059-72. PubMed ID: 9377205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dexfenfluramine on eating habits in a Dutch ambulatory android overweight population with an overconsumption of snacks.
    Drent ML; Zelissen PM; Koppeschaar HP; Nieuwenhuyzen Kruseman AC; Lutterman JA; van der Veen EA
    Int J Obes Relat Metab Disord; 1995 May; 19(5):299-304. PubMed ID: 7647820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of dexfenfluramine on weight loss and cardiovascular risk factors in female patients with upper and lower body obesity.
    Ditschuneit HH; Flechtner-Mors M; Adler G
    J Cardiovasc Risk; 1996 Aug; 3(4):397-403. PubMed ID: 8946272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetine.
    Caccia S; Confalonieri S; Bergami A; Fracasso C; Anelli M; Garattini S
    Pharmacol Biochem Behav; 1997 Aug; 57(4):851-6. PubMed ID: 9259015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for preventing weight gain after smoking cessation.
    Farley AC; Hajek P; Lycett D; Aveyard P
    Cochrane Database Syst Rev; 2012 Jan; 1():CD006219. PubMed ID: 22258966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexfenfluramine, fluoxetine, and weight loss among female carbohydrate cravers.
    Wurtman J; Wurtman R; Berry E; Gleason R; Goldberg H; McDermott J; Kahne M; Tsay R
    Neuropsychopharmacology; 1993 Nov; 9(3):201-10. PubMed ID: 8280344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain.
    Nørregaard J; Jørgensen S; Mikkelsen KL; Tønnesen P; Iversen E; Sørensen T; Søeberg B; Jakobsen HB
    Clin Pharmacol Ther; 1996 Dec; 60(6):679-86. PubMed ID: 8988071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
    Kalia M; O'Callaghan JP; Miller DB; Kramer M
    Brain Res; 2000 Mar; 858(1):92-105. PubMed ID: 10700602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
    Garattini S; Bizzi A; Caccia S; Mennini T
    Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group.
    Weissman NJ; Tighe JF; Gottdiener JS; Gwynne JT
    N Engl J Med; 1998 Sep; 339(11):725-32. PubMed ID: 9731088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine.
    Cheetham SC; Viggers JA; Slater NA; Heal DJ
    Neuropharmacology; 2000 Aug; 39(11):2028-35. PubMed ID: 10963746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for preventing weight gain after smoking cessation.
    Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition.
    Poyurovsky M; Pashinian A; Gil-Ad I; Maayan R; Schneidman M; Fuchs C; Weizman A
    Am J Psychiatry; 2002 Jun; 159(6):1058-60. PubMed ID: 12042201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotoninergic manipulation, meal-induced satiety and eating pattern: effect of fluoxetine in obese female subjects.
    Lawton CL; Wales JK; Hill AJ; Blundell JE
    Obes Res; 1995 Jul; 3(4):345-56. PubMed ID: 8521151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.